Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
134 hedge funds and large institutions have $860M invested in Sciclone Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 56 reducing their positions, and 27 closing their positions.
22,000% more call options, than puts
Call options by funds: $221K | Put options by funds: $1K
124% more capital invested
Capital invested by funds: $383M → $860M (+$477M)
8% less funds holding
Funds holding: 146 → 134 (-12)
13% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 56
44% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$3.41M |
| 2 |
SAMC
Shinko Asset Management Company
Tokyo,
Japan
|
+$3.41M |
| 3 |
MCM
Matarin Capital Management
New York
|
+$2.35M |
| 4 |
Morgan Stanley
New York
|
+$2.22M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$7.65M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.06M |
| 3 |
EDRAMF
Edmond de Rothschild Asset Management (France)
Paris,
France
|
-$3.05M |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$3.05M |
| 5 |
Millennium Management
New York
|
-$2.95M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CSS
151
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$170K | -17,336 | Closed |
|
|
AL
152
Airain Ltd
St. Peter Port,
Guernsey
| – | -$154K | -15,635 | Closed |
|
153
Principal Financial Group
Des Moines,
Iowa
| – | -$134K | -13,635 | Closed |
|
|
DC
154
Deere & Company
Moline,
Illinois
| – | -$127K | -12,981 | Closed |
|
155
Marshall Wace
London,
United Kingdom
| – | -$118K | -11,991 | Closed |
|
156
Squarepoint
New York
| – | -$115K | -11,700 | Closed |
|
|
JG
157
Jefferies Group
New York
| – | -$73K | -7,420 | Closed |
|
|
MOACM
158
Mutual of America Capital Management
New York
| – | -$53K | -5,400 | Closed |
|
|
OA
159
OFI Advisors
Philadelphia,
Pennsylvania
| – | -$28K | -2,843 | Closed |
|
|
FMA
160
FNY Managed Accounts
New York
| – | -$18.7K | -1,900 | Closed |
|
161
Simplex Trading
Chicago,
Illinois
| – | +$9 | +1 | New |
|
SCLN Hedge Fund Activity: Q3 2015 in Review
134 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2015, worth a combined $860M — up 124% from $383M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of SCLN and 15 opened new positions — a net loss of 12 holders — while 56 trimmed existing stakes and 49 added.
The largest buyer was Fisher Asset Management, opening a new position worth an estimated $3.41M. The largest seller was Nantahala Capital Management, cutting an estimated $7.65M.
- 134 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2015, down from 146 in Q2 2015.
- Funds reported $860M of Sciclone Pharmaceuticals Inc stock for Q3 2015, up 124% quarter-over-quarter.
- 15 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2015 and 27 closed out, a net change of -12 holders.
- The largest Sciclone Pharmaceuticals Inc buyer in Q3 2015 was Fisher Asset Management, an estimated $3.41M added.
- The largest Sciclone Pharmaceuticals Inc seller in Q3 2015 was Nantahala Capital Management, an estimated $7.65M sold.
Based on aggregated 13F filings for Q3 2015.